MENU
+Compare
SHTDF
Stock ticker: OTC
AS OF
Aug 28 closing price
Price
$2.42
Change
+$0.13 (+5.68%)
Capitalization
7.42B

SHTDF stock forecast, quote, news & analysis

Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009... Show more

SHTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for SHTDF with price predictions
Sep 05, 2025

Momentum Indicator for SHTDF turns positive, indicating new upward trend

SHTDF saw its Momentum Indicator move above the 0 level on August 28, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SHTDF just turned positive on August 29, 2025. Looking at past instances where SHTDF's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 157 cases where SHTDF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

SHTDF broke above its upper Bollinger Band on August 28, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.672) is normal, around the industry mean (7.650). P/E Ratio (7.926) is within average values for comparable stocks, (23.860). Projected Growth (PEG Ratio) (2.312) is also within normal values, averaging (2.524). Dividend Yield (0.039) settles around the average of (0.031) among similar stocks. P/S Ratio (0.094) is also within normal values, averaging (141.395).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SHTDF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SHTDF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

A.I.Advisor
published Dividends

SHTDF paid dividends on August 10, 2021

Sinopharm Group Co. Ltd. SHTDF Stock Dividends
А annual dividend of $0.03 per share was paid with a record date of August 10, 2021, and an ex-dividend date of June 16, 2021. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 10.23B. The market cap for tickers in the group ranges from 557.05K to 85.5B. MCK holds the highest valuation in this group at 85.5B. The lowest valued company is CNBI at 557.05K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was -1%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 1%. OMI experienced the highest price growth at 15%, while COSM experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was -30%. For the same stocks of the Industry, the average monthly volume growth was -68% and the average quarterly volume growth was -31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 56
Price Growth Rating: 57
SMR Rating: 85
Profit Risk Rating: 84
Seasonality Score: -8 (-100 ... +100)
View a ticker or compare two or three
SHTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalDistributors

Profile
Fundamentals
Details
Industry
N/A
Address
No. 385, East Longhua Road
Phone
N/A
Employees
114766
Web
http://www.sinopharmgroup.com.cn